Technology | Cardiovascular Ultrasound | July 02, 2019

Philips Extends Advanced Automation on Epiq CVx Cardiovascular Ultrasound Platform

Platform provides advanced automation for right ventricle volumes and ejection fraction measurements in as little as 15 seconds, speeding exam times

3D Auto RV application image courtesy of Philips Healthcare

3D Auto RV application image courtesy of Philips Healthcare

AutoStrain LV application image courtesy of Philips Healthcare

AutoStrain LV application image courtesy of Philips Healthcare

July 2, 2019 — Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound systems. With Release 5.0, both systems now include automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct.1 Together, the new applications provide clinicians with the means to confidently evaluate the heart’s function, increasing diagnostic confidence for patients with pulmonary hypertension, congenital heart disease, coronary disease and heart failure.

According to Philips, the company is leveraging artificial intelligence (AI) to make echo exams easier, faster and more reproducible, eliminating barriers to accessing high-quality care. The company said the new release of Epiq CVx reduces the number of touches of the system by 21 percent in each exam, which is equivalent to more than 400 exams each year.2

The AutoStrain LV application uses advanced Automatic View Recognition technology to identify the different views of the heart, providing high-quality visualization and analysis of left ventricular function – extremely important diagnostic information for patients at risk of developing cardiovascular disease. Also available are AutoStrain LA and AutoStrain RV, applications which automate the measurement of left atrial and right ventricular longitudinal strain, respectively. By creating reliable and reproducible strain measurements for the left ventricle, left atrium and right ventricle, the AutoStrain LV, LA and RV applications support clinicians treating patients with atrial fibrillation, arrhythmia and other complex heart conditions.

The 3D Auto RV application segments, identifies the borders of and aligns the views of the right ventricle, enabling clinicians to carry out the quantification and check the measurements in as little as 15 seconds.3 

These new applications expand on the advanced automation applications already available on the Epiq CVx platform, including Dynamic HeartModel, which provides a clear vision of the heart’s chambers and how well they are pumping blood – specifically on the left side, where heart failure often begins. A recent study of Dynamic HeartModel published in the European Heart Journal – Cardiovascular Imaging concluded that ‘the automated algorithm can quickly measure dynamic left ventricle and left atrial volumes and accurately analyze ejection/filling parameters’.4

The new release also adds diagnostic capabilities to the Epiq CVxi. Tailored for use in the interventional lab, the system can now also be used in the echo lab.

Beyond monitoring overall heart function, new medical fields such as cardio-oncology are using echocardiography to better assess heart health during chemotherapy, which can damage the heart if the dosage is not closely monitored. Cardio-oncology has increased the global demand for echocardiography as clinicians need to perform a deep analysis on cardiac images throughout the patient’s treatment, ensuring measurements are consistent from one exam to the next so that the results can be reliably compared.

Philips unveiled Epiq CVx Release 5.0 alongside its full suite of solutions for diagnosis and interventional guidance during the annual meeting of the American Society of Echo (ASE), June 21-25 in Portland, Ore. 

For more information: www.usa.philips.com/healthcare

 

References

1. The Philips CVx and CVxi 5.0 Diagnostic ultrasound systems are available for sale globally. The AutoStrain LV, LA, RV applications and the Dynamic Heart Model application are CE marked and U.S. Food and Drug Administration (FDA)-cleared and available for sale in Europe and in the U.S. The AI-enabled 3D AutoRV application, designed using a machine learning-based algorithm, is CE marked and FDA 510(k) pending, and is therefore available for sale in Europe but is not available for sale in the U.S.

2. Based on eight scans per day over 48 weeks.

3. Based on internal test results.

4. European Heart Journal – Cardiovascular Imaging, “Machine learning based automated dynamic quantification of left heart chambers volumes,” October 9, 2018.

Related Content

AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of
In response to the significant healthcare delivery changes brought on by COVID-19, Varian has launched new capabilities for its Noona software application, a powerful tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.
News | Radiation Oncology | May 21, 2020
May 21, 2020 — In response to the significant healthcare delivery changes brought on by...